Oxbow Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-76,201
| Closed | -$3.91M | – | 225 |
|
2023
Q4 | $3.91M | Buy |
+76,201
| New | +$3.91M | 0.59% | 46 |
|
2019
Q3 | – | Sell |
-23,152
| Closed | -$1.05M | – | 298 |
|
2019
Q2 | $1.05M | Sell |
23,152
-33,764
| -59% | -$1.53M | 0.13% | 150 |
|
2019
Q1 | $2.72M | Buy |
56,916
+3,065
| +6% | +$146K | 0.33% | 74 |
|
2018
Q4 | $2.8M | Buy |
53,851
+35,956
| +201% | +$1.87M | 0.37% | 60 |
|
2018
Q3 | $1.11M | Buy |
+17,895
| New | +$1.11M | 0.13% | 139 |
|
2017
Q2 | – | Sell |
-20,716
| Closed | -$1.13M | – | 239 |
|
2017
Q1 | $1.13M | Buy |
20,716
+581
| +3% | +$31.6K | 0.18% | 126 |
|
2016
Q4 | $1.18M | Sell |
20,135
-41,096
| -67% | -$2.4M | 0.15% | 129 |
|
2016
Q3 | $3.3M | Sell |
61,231
-2,961
| -5% | -$160K | 0.45% | 68 |
|
2016
Q2 | $4.72M | Sell |
64,192
-5,718
| -8% | -$421K | 0.68% | 42 |
|
2016
Q1 | $4.47M | Sell |
69,910
-5,158
| -7% | -$330K | 0.63% | 44 |
|
2015
Q4 | $5.16M | Buy |
75,068
+9,070
| +14% | +$624K | 0.65% | 45 |
|
2015
Q3 | $3.91M | Sell |
65,998
-8,127
| -11% | -$481K | 0.64% | 43 |
|
2015
Q2 | $4.93M | Sell |
74,125
-2,550
| -3% | -$170K | 0.64% | 42 |
|
2015
Q1 | $4.95M | Buy |
+76,675
| New | +$4.95M | 0.74% | 40 |
|
2014
Q2 | – | Sell |
-26,035
| Closed | -$1.35M | – | 217 |
|
2014
Q1 | $1.35M | Sell |
26,035
-7,995
| -23% | -$415K | 0.2% | 97 |
|
2013
Q4 | $1.81M | Buy |
34,030
+15,430
| +83% | +$820K | 0.26% | 92 |
|
2013
Q3 | $861K | Sell |
18,600
-550
| -3% | -$25.5K | 0.14% | 113 |
|
2013
Q2 | $856K | Buy |
+19,150
| New | +$856K | 0.15% | 101 |
|